Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 7, 2016; 22(41): 9104-9116
Published online Nov 7, 2016. doi: 10.3748/wjg.v22.i41.9104
Published online Nov 7, 2016. doi: 10.3748/wjg.v22.i41.9104
Table 1 Inflammatory bowel disease patient demographics and characteristic
| Characteristics | n or mean ± SD (range) |
| Male:female | 7:11 |
| Age at diagnosis(yr) | 26.6 ± 11.3 (12-56) |
| Disease duration | 8.4 ± 7.9 (0-30) |
| Montreal classification | |
| CD | 13 |
| UC | 5 |
| Age at diagnosis (yr) | |
| A1 ( ≤ 16) | 1 |
| A2 (17-40) | 14 |
| A3 (> 40) | 3 |
| Smoking status | |
| Never smoked | 7 |
| Ex-smoker | 5 |
| Current smoker | 6 |
| Anti-TNF response | |
| Responder | 13 |
| Non-responder | 5 |
- Citation: Baird AC, Mallon D, Radford-Smith G, Boyer J, Piche T, Prescott SL, Lawrance IC, Tulic MK. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy. World J Gastroenterol 2016; 22(41): 9104-9116
- URL: https://www.wjgnet.com/1007-9327/full/v22/i41/9104.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i41.9104